Amping up cognition: the curcumin story

Supplementation of curcumin may boost cognition in healthy older adults, results from a recently published study in the Journal of Psychopharmacology point out. Specifically, the study was a randomized, double-blind, placebo-controlled trial that examined the acute and chronic effects of 400 mg L...

This item has been archived in line with our efforts to keep our content relevant and up to date for our readership. For further assistance, please contact your Customer Success Manager or email ClientEngagementTeam@luxresearchinc.com. Thank you!

Related Research

Biogen's Alzheimer's disease drug approval triggers controversy but also hints at new business opportunities

Analyst Insight | June 08, 2021

Biogen's recent FDA approval for an Alzheimer's disease (AD) drug is arguably the biggest news this week in the healthcare industry. Both Biogen's and its development partner Eisai's stock prices jumped more than 50% on the announcement. Yet, many dementia experts were quick to point out that the ... Not part of subscription

Prevailing theory on Alzheimer's disease (AD) is challenged by new research finding

News Commentary | June 29, 2021

Biogen's recent FDA approval for its AD drug continues to trigger controversy, as we have discussed here and here. Part of the reason is that the drug is based on the "amyloid hypothesis," which posits that accumulation of amyloid‑beta plaques is the main cause of AD. New research findings, however... To read more, click here.

Colgate-Palmolive publishes scientific study outlining prebiotic effect of active personal care ingredient

News Commentary | September 09, 2021

R&D researchers from the company recently published data from in vitro studies and small‑scale human clinical trial, outlining the effect of 2‑butyloctanol in selectively inhibiting the growth of odor‑causing Corynebacterium while promoting the growth of good bacterium Staphylococcus epidermidis... Not part of subscription